EX-99.3 3 dr0478_ex99-3.htm EXHIBIT 99.3

 

Exhibit 99.3

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel:      +91 40 4900 2900

Fax:      +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

May 11, 2023

 

To,

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub: Copies of newspaper advertisement regarding audited financial results for the quarter and year ended March 31, 2023

 

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed copies of newspaper advertisement regarding the audited financial results of the company for the quarter and year ended March 31, 2023, as published in Business Standard and Andhra Prabha on May 11, 2023.

 

This is for your information and records

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

/s/ K Randhir Singh  
K Randhir Singh  
Company Secretary, Compliance Officer and Head-CSR  

 

Encl: as above